Zacks Research Has Positive Outlook for Itron Q4 Earnings

Itron, Inc. (NASDAQ:ITRIFree Report) – Equities research analysts at Zacks Research upped their Q4 2024 earnings estimates for Itron in a report released on Tuesday, November 19th. Zacks Research analyst R. Department now expects that the scientific and technical instruments company will post earnings per share of $1.02 for the quarter, up from their previous estimate of $0.92. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q3 2025 earnings at $1.19 EPS, Q2 2026 earnings at $1.32 EPS, Q3 2026 earnings at $1.38 EPS and FY2026 earnings at $5.29 EPS.

Itron (NASDAQ:ITRIGet Free Report) last posted its quarterly earnings results on Thursday, October 31st. The scientific and technical instruments company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.71. The firm had revenue of $615.46 million for the quarter, compared to analysts’ expectations of $596.41 million. Itron had a net margin of 9.37% and a return on equity of 19.03%. The firm’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.98 earnings per share.

Several other equities research analysts also recently weighed in on the stock. Piper Sandler upped their price objective on shares of Itron from $110.00 to $119.00 and gave the stock a “neutral” rating in a report on Friday, November 1st. Robert W. Baird upped their price target on shares of Itron from $123.00 to $132.00 and gave the company an “outperform” rating in a report on Friday, November 1st. BNP Paribas began coverage on shares of Itron in a report on Thursday, September 5th. They issued an “outperform” rating and a $133.00 price target for the company. TD Cowen upped their price objective on shares of Itron from $125.00 to $136.00 and gave the company a “buy” rating in a research note on Friday, November 1st. Finally, Stephens reaffirmed an “equal weight” rating and set a $110.00 price objective on shares of Itron in a research note on Monday, August 5th. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $123.92.

View Our Latest Stock Analysis on ITRI

Itron Stock Up 1.9 %

ITRI stock opened at $116.25 on Thursday. The company has a debt-to-equity ratio of 0.91, a current ratio of 3.36 and a quick ratio of 2.83. Itron has a 1-year low of $65.20 and a 1-year high of $124.90. The firm has a fifty day moving average price of $108.87 and a two-hundred day moving average price of $104.86. The firm has a market cap of $5.24 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 0.86 and a beta of 1.46.

Institutional Trading of Itron

A number of hedge funds and other institutional investors have recently made changes to their positions in ITRI. Silvercrest Asset Management Group LLC acquired a new stake in shares of Itron in the first quarter valued at $401,000. Erste Asset Management GmbH acquired a new stake in Itron in the third quarter worth about $38,534,000. Handelsbanken Fonder AB increased its position in Itron by 62.7% in the third quarter. Handelsbanken Fonder AB now owns 899,789 shares of the scientific and technical instruments company’s stock worth $96,106,000 after purchasing an additional 346,615 shares during the period. Select Equity Group L.P. increased its position in Itron by 86.2% in the second quarter. Select Equity Group L.P. now owns 603,877 shares of the scientific and technical instruments company’s stock worth $59,760,000 after purchasing an additional 279,629 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in Itron by 90.7% in the third quarter. Assenagon Asset Management S.A. now owns 511,734 shares of the scientific and technical instruments company’s stock worth $54,658,000 after purchasing an additional 243,355 shares during the period. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Itron news, CEO Thomas Deitrich sold 887 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $102.15, for a total transaction of $90,607.05. Following the completion of the transaction, the chief executive officer now directly owns 205,276 shares in the company, valued at $20,968,943.40. This represents a 0.43 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Joan S. Hooper sold 509 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $102.15, for a total value of $51,994.35. Following the transaction, the chief financial officer now owns 72,338 shares of the company’s stock, valued at $7,389,326.70. This represents a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,066 shares of company stock valued at $4,092,737 over the last ninety days. 1.45% of the stock is owned by company insiders.

About Itron

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Read More

Earnings History and Estimates for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.